Favorable outcome on viral load and culture viability using Ivermectin in early treatment of non-hospitalized patients with mild COVID-19 – A double-blind, randomized placebo-controlled trial

Asaf Biber, Michal Mandelboim, Geva Harmelin, Dana Lev, Li Ram, Amit Shaham, Ital Nemet, Limor Kliker, Oran Erster, Eli Schwartz
doi: https://doi.org/10.1101/2021.05.31.21258081

Data Availability

All data supporting the results will be provided by the corresponding author upon publication.

Back to top
Posted May 31, 2021.
Download PDF

Supplementary Material

Data/Code
Email
Favorable outcome on viral load and culture viability using Ivermectin in early treatment of non-hospitalized patients with mild COVID-19 – A double-blind, randomized placebo-controlled trial
Asaf Biber, Michal Mandelboim, Geva Harmelin, Dana Lev, Li Ram, Amit Shaham, Ital Nemet, Limor Kliker, Oran Erster, Eli Schwartz
medRxiv 2021.05.31.21258081; doi: https://doi.org/10.1101/2021.05.31.21258081
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area